Fortune News on January 14, the Hang Seng Index narrowed its afternoon decline. As of press time, the Hang Seng Index fell 0.5%, or 121 points, to 24307, while the Hang Seng Technology Index fell 1.01%.

Hong Kong Shipping stocks rose against the trend$Orient Overseas (00316.HK) $Increase by more than 8%$SITC International Holdings (01308.HK) $Increase by more than 6%$COSCO Shipping Holdings (01919.HK) $Increase by more than 2%$Pacific Shipping (02343.HK) $It's up more than 1%.

Recently, international shipping companies, including Evergreen, HMM, ONE and so on, have issued price increase announcements and decided to raise the comprehensive rate surcharge (GRI) from Asia to the United States from February 1, with an average increase of about 10%. Industry insiders pointed out that the sharp rise in freight rates in Southeast Asia has prompted shipping companies to send cleaning vessels to speed up the clearance of US-West empty containers back to Asia to take advantage of high-price business opportunities on the Asian line.

Hong Kong stock anti-epidemic concept stocks rose$Junshi creature (01877.HK) $Increase by more than 15%$Shanghai Fosun Pharmaceutical (02196.HK) $、$CANSINOBIO-B (06185.HK) $、$Dongyang Light Medicine (01558.HK) $Increase by more than 3%$CSPC Pharmaceutical (01093.HK) $、$Golly Pharmaceuticals-B (01672.HK) $、$Baiyun Mountain (00874.HK) $Increase by more than 2%

On the news side, O'Micron novel coronavirus is further global spread. In response to O'Micron, US President Joe Biden instructed the US government to purchase an additional 500 million COVID-19 test kits to help meet demand across the country during the spread of the Omicron variant, while providing the most protective N95 masks free of charge.

In addition, Junshi Biological announced on December 31st that the Ministry of Health of Uzbekistan has approved its emergency use authorization for oral nucleoside anti-novel coronavirus drug VV116, and VV116 has also become the fourth oral drug approved for COVID-19 's treatment in the world after opening up the pharmaceutical industry Puclosamide, Merck & Co Inc Molnupiravir, and Pfizer Inc Paxlovid.

In addition, Junshi Bio said that VV116 is actively promoting clinical trials in China and Uzbekistan, and has been authorized for emergency use in Uzbekistan, and the clinical research of the project is progressing smoothly, and the clinical progress of related products and the results of follow-up trials need to be evaluated after the completion of the overall clinical trial.

Gaming stocks rose in the afternoon.$Sands China Ltd. (01928.HK) $Increase by more than 5%$Galaxy Entertainment (00027.HK) $、SJM Holdings (00880.HK) $、Wynn Macau (01128.HK) $Increase by more than 2%$MGM China (02282.HK) $It's up more than 1%.

$Sunny Optical Technology (02382.HK) $It has risen by more than 1%, after falling by more than 3%. Sunny Optical Technology announced that it would suspend the subscription of a 6 per cent stake in Chongqing Ant Consumer Finance.

According to the Futuo Niuniu Hong Kong stock trading hot list today, the top stocks include Tencent, Meituan, Kuaishou Technology, BABA, HSBC Holdings PLC, JD.com Group and so on.